Intestinal Obstruction Completed Phase 3 Trials for Lanreotide (DB06791)

Back to Intestinal Obstruction

Also known as: Obstruction Bowel / Bowel Obstruction / Other intestinal obstruction / Unspecified intestinal obstruction / Unspecified intestinal obstruction, unspecified as to partial versus complete obstruction / Obstruction intestinal / Intestinal obstruction (disorder) / Intestinal obstruction NOS

Indication	Status	Phase
DBCOND0031423 (Intestinal Obstruction)	Completed	3

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT00216372	Efficacy and Safety of Lanreotide Microparticles as Palliative Treatment in Peritoneal Carcinomatosis	Treatment	Lanreotide (DB06791)